Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-034701
Filing Date
2021-05-20
Accepted
2021-05-20 20:33:26
Documents
2
Period of Report
2021-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6059
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3644
  Complete submission text file 0001209191-21-034701.txt   11082
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Issuer) CIK: 0001664106 (see all company filings)

EIN.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 65 HAYDEN AVENUE 2ND FLOOR LEXINGTON MA 02421
Business Address
Gruskin Daniel (Reporting) CIK: 0001863053 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38707 | Film No.: 21946302